UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $422,530 | -43.2% | 36,870 | -0.2% | 0.00% | -42.9% |
| Q1 2023 | $744,092 | +118386.0% | 36,946 | +33.4% | 0.01% | -30.0% |
| Q4 2022 | $628 | -99.9% | 27,696 | -6.4% | 0.01% | +11.1% |
| Q3 2022 | $555,000 | +14.0% | 29,577 | +13.1% | 0.01% | +12.5% |
| Q2 2022 | $487,000 | +5.4% | 26,142 | +2.3% | 0.01% | +33.3% |
| Q1 2022 | $462,000 | -14.3% | 25,556 | -1.6% | 0.01% | -14.3% |
| Q4 2021 | $539,000 | -36.7% | 25,982 | -2.3% | 0.01% | -30.0% |
| Q3 2021 | $851,000 | – | 26,584 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |